Balaji Gandhi Biography and Net Worth

CFO of Phreesia

As Chief Financial Officer, Balaji Gandhi leverages more than 25 years of executive experience to oversee the company’s budgeting, forecasting, monthly reporting, financial analysis, internal controls and investor relations.

Prior to joining Phreesia, he spent nearly a decade in leadership roles at companies including Madaket Health, Press Ganey and Fresenius Medical Care, where he worked across finance, corporate development, strategy and investor relations. He also spent more than a decade as an investment research analyst in the healthcare services market at several financial and investment firms, including Deutsche Bank, GE Capital and Oppenheimer & Co., Inc. Balaji holds a master’s degree in health services administration from The George Washington University and a BA from the University of Rochester.

What is Balaji Gandhi's net worth?: The estimated net worth of Balaji Gandhi is at least $2.01 million as of October 17th, 2025. Mr. Gandhi owns 98,240 shares of Phreesia stock worth more than $2,013,429 as of December 5th. This net worth estimate does not reflect any other investments that Mr. Gandhi may own. Learn More about Balaji Gandhi's net worth.
How old is Balaji Gandhi?: Mr. Gandhi is currently 50 years old. There are 6 older executives and no younger executives at Phreesia. The oldest executive at Phreesia is Ms. Janet M. Gunzburg, VP, Principal Accounting Officer & Controller, who is 58 years old. Learn More on Balaji Gandhi's age.
How do I contact Balaji Gandhi?: The corporate mailing address for Mr. Gandhi and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Balaji Gandhi's contact information.
Has Balaji Gandhi been buying or selling shares of Phreesia?: During the last quarter, Balaji Gandhi has sold $19,788.60 in shares of Phreesia stock. Most recently, Balaji Gandhi sold 885 shares of the business's stock in a transaction on Friday, October 17th. The shares were sold at an average price of $22.36, for a transaction totalling $19,788.60. Following the completion of the sale, the chief financial officer now directly owns 98,240 shares of the company's stock, valued at $2,196,646.40. Learn More on Balaji Gandhi's trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Lisa Egbuonu-Davis (Director), Balaji Gandhi (CFO), Allison Hoffman (General Counsel), Yvonne Hui (VP, Principal Accounting Officer), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Mark Smith (Director), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 88 times. They sold a total of 384,262 shares worth more than $10,656,070.27. The most recent insider tranaction occured on October, 17th when CFO Balaji Gandhi sold 885 shares worth more than $19,788.60. Insiders at Phreesia own 5.5% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 10/17/2025.

Balaji Gandhi Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/17/2025	Sell	885	$22.36	$19,788.60	98,240
9/16/2025	Sell	4,183	$23.28	$97,380.24	99,125
7/17/2025	Sell	886	$26.89	$23,824.54	106,661
4/16/2025	Sell	864	$23.81	$20,571.84	107,547
4/8/2025	Sell	8,045	$23.85	$191,873.25	108,411
3/26/2025	Sell	1,827	$27.46	$50,169.42	103,591
2/18/2025	Sell	5,771	$30.04	$173,360.84	105,514
2/13/2025	Sell	28,759	$30.00	$862,770.00	116,174
1/27/2025	Sell	4,813	$27.48	$132,261.24	144,933
1/21/2025	Sell	5,827	$27.31	$159,135.37	141,846
1/15/2025	Sell	836	$26.98	$22,555.28	147,673
1/6/2025	Sell	3,195	$26.61	$85,018.95	148,509
10/15/2024	Sell	864	$21.03	$18,169.92	97,714
9/10/2024	Sell	3,502	$23.25	$81,421.50	98,578
7/16/2024	Sell	783	$23.74	$18,588.42	96,447
4/15/2024	Sell	948	$22.86	$21,671.28	97,230
4/8/2024	Sell	7,778	$22.62	$175,938.36	98,178
3/25/2024	Sell	3,504	$23.21	$81,327.84	94,030
1/16/2024	Sell	932	$24.55	$22,880.60	106,726
10/16/2023	Sell	861	$16.61	$14,301.21	85,658
9/13/2023	Sell	3,957	$20.34	$80,485.38	86,519
4/17/2023	Sell	2,113	$31.83	$67,256.79	85,738

Balaji Gandhi Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $20.50

$20.27

$20.67

50 Day Range

MA: $22.16

$19.08

$23.88

2 Week Range

Now: $20.50

$18.55

$32.76

Volume

825,679 shs

Average Volume

754,359 shs

Market Capitalization

$1.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Balaji Gandhi Biography and Net Worth

What is Balaji Gandhi's net worth?

How old is Balaji Gandhi?

How do I contact Balaji Gandhi?

Has Balaji Gandhi been buying or selling shares of Phreesia?

Who are Phreesia's active insiders?

Are insiders buying or selling shares of Phreesia?